Musculoskeletal Diseases clinical trials at University of California Health
2 in progress, 0 open to eligible people
Showing trials for
Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping
Sorry, not accepting new patients
The purpose of this Managed Access Program is to allow access to delpacibart zotadirsen (AOC 1044) for eligible patients diagnosed with DMD mutations amenable to exon 44 skipping. The patient's Administering Physician should follow the suggested treatment guidelines and comply with all local health authority regulations.
at UC Irvine
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization
Sorry, in progress, not accepting new patients
An open label, prospective, two-arm, multicenter, randomized controlled trial comparing SakuraBead genicular artery embolization (GAE) with a control (corticosteroid injection).
at UCLA
Last updated: